Varicella-zoster virus reactivation and cardiovascular risk: implications for patients receiving JAK inhibitors

Annals of the Rheumatic Diseases · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles